chrisvoncsefalvay/vaers-outcomes huggingface dataset:
FACIAL SWELLING; DRY COUGH; DIZZY; FLU LIKE SYMPTOMS; HEADACHE; FEVER; TIREDNESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included edema, copd, asthma, htn, seizure, sleep apnea, and hashimotos. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 16-MAR-2021 on right arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced dizzy. On MAR-2021, the subject experienced flu like symptoms. On MAR-2021, the subject experienced headache. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced tiredness. On 20-MAR-2021, the subject experienced facial swelling. On 20-MAR-2021, the subject experienced dry cough. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, facial swelling, dry cough, fever, tiredness, dizzy and flu like symptoms was not reported. This report was non-serious.
rapid heart rate; shortness of breath that wasn't sever; hurts to sit; very sore; like someone crashed in her right side; headache; severe discomfort; A spontaneous report was received from a consumer concerning a 65-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rapid heart rate, shortness of breath that wasn't sever, hurts to sit, very sore, like someone crashed in her right side, headache, severe discomfort.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 17 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 045A21A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 17 Mar 2021, the patient experienced the event(s) rapid heart rate, shortness of breath that wasn't sever, hurts to sit, very sore, like someone crashed in her right side, headache, severe discomfort.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  On 18 Mar 2021 the outcome of event(s), rapid heart rate, shortness of breath that wasn't sever was resolved. On19 Mar 2021 the outcome of event(s), hurts to sit, very sore, like someone crashed in her right side, headache, severe discomfort was resolved.
PATIENT NOTICED A BLISTER LOOKING AT THE INJECTION SITE OF HIS LEFT ARM, WHERE HE GOT RSV SHOT, ON SEPTEMBER 19TH (A WEEK FROM RECEIVING HIS SHOTS). HE CLAIMS THAT THIS BLISTER HAS BEEN POPPED AFTER HE NOTICED BUT DOES NOT FEEL ANY PAIN NOR SWELLING HAS SHOWN
Started having body aches at 1800 the day of administration.  Continues to have mild headache and body aches.
In conjunction with temporary VAERs # 414873 submitted on 7Apr21. My fever lasted nine days and required a trip to the ER.   Was 104.3 on 9Apr21 and was 102.9 14Apr21. My normal temperature is 97.4.  Took mostly Acetaminophen and some Ibuprofen.   Was well hydrated.
Child was given Vaqta, then Gardasil vaccine.  She immediately felt faint-slumped over (was helped to lay down on exam table) and "eyes rolled back". Child became responsive quickly
Tinnitus, fainting, low blood pressure. Chills when  IV was administered. Two bags of IV administered.   As of today, day five, still have ringing in the ears (tinnitus).
stuffy nose/congestion; chills; swollen lymp nodes on left arm injection site; nose always dry; arm pain; erythema around the vaccine site; tingly sensation on the lips; tingly sensation on the tip of nose; A spontaneous report  was received from a 38 year old female consumer who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced tingly sensation on tip of nose (paraesthesia) and lips (paraesthesia oral), weird stuffy nose (nasal congestion) and dryness (nasal dryness), arm pain (pain in extremity), swollen lymph nodes on left arm injections site (injection site lymphadenopathy), chills, and erythema around injection site (injection site erythema).    The patient's medical history was not provided.  No relevant concomitant medications were reported.   On 23 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot 011J20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 23 Dec 2020 after the vaccine was administered, the patient reports that she had immediate reaction, tingly sensation on the tip of nose and lips. After, the patient experienced weird stuff nose, not congested but dry, arm pain, swollen lymph nodes on left arm injection site and chills. On 30 Dec 2020, the patient experienced erythema around the vaccine site. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events of weird stuffy nose and dryness, arm pain, swollen lymph nodes on left arm injections site, chills and erythema around injection site, were unknown.  The events of tingly sensation on tip of nose and lips was resolved on 23 Dec 2020.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
This spontaneous case reported by a consumer, describes the occurrence of product dose omission issue (more than 35 days since the first shot) and vaccination complication (health issues after receiving the vaccine) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the 1st dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced product dose omission issue (more than 35 days since the first shot) and vaccination complication (health issues after receiving the vaccine). At the time of the report, product dose omission issue (more than 35 days since the first shot) and vaccination complication (health issues after receiving the vaccine) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported. Patient also reported experiencing some medical issues.
Headache Body aches Chills Fever  Nausea/vomiting  Fatigue  Lasting two days
Pt experienced chills, strong malaise , migraine  the day after vaccination. Pt was given 3 doses total of this vaccine in error.
Narrative:  A 76yo male with PMH of Sensorineural hearing Loss of combined Type, HTN, Obesity, Vitamin D deficiency, PTSD, B12 deficiency, Heart Murmur, PTSD, Carcinoma of Prostate, Paroxysmal A-fib, PE, Metastasis to Brain Per Nurse's documentation- He received Covid- 19 vaccine per policy and protocol without complication First dose on February 15, 2021 No ADE was reported Patient with Carcinoma of prostate and metastasis to the Brain note documentation - patient passed away on March 16, 2021
12 hours after injection, I developed a fever with chills and flu-like symptoms which lasted the next 12 hours. 24 hours after the injection, the fever broke and the symptoms were gone. Additionally for posterity, I did not have any allergic reaction, become magnetic, or develop autism.
A patient developed a bilateral groin and armpit rash/The rash was not itchy or bothersome; Just a solid red rash; This spontaneous case was reported by a physician and describes the occurrence of RASH (A patient developed a bilateral groin and armpit rash/The rash was not itchy or bothersome) and RASH ERYTHEMATOUS (Just a solid red rash) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (patient developed rash after becoming infected with COVID) and Viral infection NOS (patient developed rash after two non COVID viral infections).    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (A patient developed a bilateral groin and armpit rash/The rash was not itchy or bothersome) and RASH ERYTHEMATOUS (Just a solid red rash). At the time of the report, RASH (A patient developed a bilateral groin and armpit rash/The rash was not itchy or bothersome) and RASH ERYTHEMATOUS (Just a solid red rash) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   It was reported that patient has ongoing viral illnesses. No concomitant medication information was provided.  The rash was not itchy or bothersome just a solid red rash. Reporter assumes rash to be an immune response they have now developed toward ongoing viral illnesses. No treatment medication information was given.   This case was linked to MOD-2022-551296 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2022: Follow-up received contains no new information.
Accidentally gave patient their second dose 1 week before it was due. Patient received 1st dose 9/3/21 &  2nd was given 9/24/21. Their vaccination card looked like it said 1st dose 8/3/21 & the patient stated the facility told him the 2nd was due in 3 weeks. Patient was alerted of the mistake & did not seem overly concerned.
45 min long chest pain between 2-3am, awoken from sleep. Tachycardia on and off along with costrocondritis for one month duration
Sweating,Chills,fever, severe muscle aches,migraine headache, vomiting. I got my second vax shot on May 24th at noon.The chills started 15 hours after the second vaccination shot. Muscle aches throughout my entire body soon after. I broke a fever in the middle of the night accompanied with a migraine headache. I did not sleep and in the morning  on May 25th I started vomiting. I still had a fever, muscle aches and headache the entire day of the 25th. The 26,27 my body aches were present.The 26,27,28, and 29th I had nausea.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs was not provided. On 07-DEC-2018, the patient was vaccinated with a properly stored but expired dose of VAQTA 25/0.5 (units were not provided), lot # N028743, expiration date 23-NOV-2018 (dose, route and anatomical location were not provided) for prophylaxis (expired product administered). No adverse effects were reported.
Approximately 20 minutes after receiving the 4th dose (2nd booster), I felt unwell. Flushed face, but no temperature. Although I had a feeling of unwellness after my  first 3 shots, that feeling did not come until the next day after I woke up.  Since April 3, my main complaints are as follows:  (1) an elevated blood pressure and heart rate reading on my at-home blood pressure monitor; (2) an "irregular heartbeat" indicator coming on after multiple, but not every reading ;(3) an occasional tingling/pins and needle feeling in my mid-back on the right side; (3) occasional pain in my right bicept, near the site of the injection.
7 days p/vax pt exp cold/canker sores & upon further exam sores had spread to inner mouth & lips. also exp a raised inject site.
Information has been received from a 75 year old female with no relevant medical history reported who on 30-NOV-2006 was vaccinated with a 0.5 mL dose of Pneumovax 23 (lot 655291/0985F).  Concomitant therapy included ezetimibe (MSD), simvastatin (MSD), diazepam, aspirin and "enduril".  On 30-NOV-2006, approximately 2 hours post vaccination, the patient developed cellulitis.  The patient sought unspecified medical attention.  At the time of this report, the patient was recovering.  Additional information has been requested.
No additional AE; HCP reported that an unknown adult patient was administered the PROQUAD and VARIVAX vaccines concomitantly.; This spontaneous report was received from a pharmacist and refers to an adult patient of unknown age and gender. No information on patient's medical history, current conditions and concomitant medications was provided.       On 12-AUG-2023 the patient was inadvertently vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (exact dose, dose number, route and site of administration, lot number and expiration date were not provided) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (exact dose, dose number, route and site of administration, lot number and expiration date were not provided) on that same day (accidental overdose and no adverse event).
Productive cough, fatigue, left arm pain at injection site with soreness, myalgia, arthralgia, headache.  Injection was on June 12. Today is June 14 and I am still symptomatic. Incidentally, I am a healthcare provider (MD, board certified Family Medicine).  I have taken ibuprofen (800 mg on June 13 and acetaminophen 1000 mg on June 14).
Patient was given pediatric pfizer vaccine and patient is 12 years old. No adverse reaction only incorrect vaccine given.
Information has been received from a physician concerning a patient who was vaccinated with 0.5 ml dose of PNEUMOVAX 23. Subsequently the patient developed rash from elbow to shoulder on the arm that received the injection. No lot number was provided. The patient had sought unknown medical attention. At the time of report the patient's status was unknown. This is one of several reports from the same source. On 15-SEP-2009 all telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
Lightheadness, felt hot, arms & legs felt heavy; shaking uncontrollably; see in ER by MD; monitored BP & HR, then discharged; still has nagging h/a 8MAR93; pt was treated for acute anaphylaxis;
Patient started he has never fainted for a vaccine before during the questionnaire. When he was paying for his vaccine he got pale and his arms started shaking. I asked if he's going to pass out and he said yes. We laid him on the floor and elevated his feet. Later he stated this happens before when he gave blood. We gave him orange juice and he sat for 20 minutes then said he feels fine and wanted to leave. He didn't want us to call EMS.
Flu like symptoms,  headache, joint pain, muscle spasms, nausea, arm tenderness, fatigue, intestinal pain, lasting over a week.  To the point that it interfered with my normal function of life
This spontaneous report as received from a medical assistant refers to an 80 years old male patient. The patient was vaccinated intramuscularly with a 1.0 ml dose of PNEUMOVAX 23 (lot number 1947AA, expiration date 20-OCT-2013) rather than 0.5ml dose on 10-AUG-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse event reported. It was unspecified if the patient sought medical attention. Additional information is not expected.
mom recv vax while 6wk pregnant;child exp on 2nd day of life free air in small bowel w/multiple perforations, surgery necessary;also exp mild hyaline membrane disease;baby passed away 14SEP96;
Patient received the Moderna Covid 19 vaccine after temperature excursion; Patient received the Moderna Covid 19 vaccine after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received the Moderna Covid 19 vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient received the Moderna Covid 19 vaccine after temperature excursion) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 21-Apr-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received the Moderna Covid 19 vaccine after temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received the Moderna Covid 19 vaccine after temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received the Moderna Covid 19 vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient received the Moderna Covid 19 vaccine after temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that there had been temperature excursions with the freezer that was happened for weeks since April 2022. Storage condition at the time of the excursion were frozen.  It was reported that Lot numbers: 065K21A and Lot numbers 045L21A had undergone temperature excursion and maximum and minimum temperatures reached were 30 Fahrenheit Degrees and minus 18.9 Fahrenheit Degrees respectively.  It was reported that the vaccines suffered 2 temperature excursions since April, both lasted less than 1 minute and date the vials moved from freezer to refrigerator was unknown, they were now stored in frozen condition and no vaccine state change was observed.  No treatment medications were reported.
Flush; temperature; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flush) and BODY TEMPERATURE INCREASED (temperature) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced FLUSHING (Flush) and BODY TEMPERATURE INCREASED (temperature). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FLUSHING (Flush) and BODY TEMPERATURE INCREASED (temperature) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.5 (High) High.         treatment includes paracetamol (Tylenol).   This case was linked to MOD-2021-036290 (Patient Link).
Began with a sharp shooting pain that radiated entiriely down the muscle of the left arm.  Days later she states it was a constant intermitten shooting pain that  at times would make her left hand cramp up and become unusable.  This lasted for 5 weeks.  At present has resolved.
Fever 102 with flu-like symptoms, one day after receiving 4 immunizations for deployment overseas.
pt walked out to registration desk & slumped over;eyes open;carried by father & nurse to exam room placed on table; BP taken x 3 (8:50 132/80, 9:05 110/60, 9:20 10/60) OJ given x 2;alert, active @ time of discharge;
no adverse events. patient was not 18 by 3 months and i was told this need to be reported
Complaint of cough, elevated temperature, runny nose/congestion, loss of taste/smell and myalgia.
fatigue; chills; fever (about 99-100F); the site of injection is sore; a moving painful lump near left shoulder blade (may be supraclavicular lymph nodes), which is warm to touch!; a moving painful lump near left shoulder blade (may be supraclavicular lymph nodes), which is warm to touch!; a moving painful lump near left shoulder blade (may be supraclavicular lymph nodes), which is warm to touch!; This is a spontaneous report from a contactable other health professional reported for herself. This 45-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EK9031) via an unspecified route of administration on 19Jan2021 at 09:15 AM at single dose in left arm for COVID-19 immunization. The patient is not pregnant. Medical history and concomitant medications were reported as none. Allergies to medications, food, or other products was reported as none. The patient previously received the first dose of BNT162B2 (Lot number EH9899) on 30Dec2020 at 11:15 AM at single dose in left arm for COVID-19 immunisation and had no symptoms; Influenza vaccine on 10Dec2020 for immunization. The patient experienced fatigue, chills followed by fever (about 99-100F) lasted for about one and half days. The site of injection is sore even after 3 days. The patient observed a moving painful lump near left shoulder blade (may be supraclavicular lymph nodes), which is warm to touch. The events onset date was reported as 21Jan2021. The events were reported as non-serious. The patient was not diagnosed with COVID-19 Prior to vaccination and not tested for COVID-19 since the vaccination. The patient received no treatment. The outcome of the events was not resolved.
client received vaccines MMR, and Hep. B. on Monday 06/08/2009. Called today.Stated on Tues night tongue became sore and swollen. Still sore and swollen today. Took Benadryl yesterday. Advised client to take more Benadryl if needed and if tongue swells any more or if client experiences any difficulty breathing to go to ER immediately.
High fever 106.2F @ 8PM; Febrile seizure 230AM; complete recovery;
Pain from shoulder down to fingertips, numbing feeling in fingertips, swelling in fingers Prednisone 13 day.
5 hours after first shot I began to feel the pain at the injection site but I also began to feel pain in my lower back at the trunk of my spine.  By the next day, March 4th I was in agony and could barely move.  But Saturday morning the pain had not dissipated even with rounds of ADVIL and TYLENOL heat and ice packs. I went to the ER as given Tramadol, Naxoproxin, Cyclobenazprine and Lidocaine patches.  I use these all weekend but I discontinued everything but the Lidocaine patches because I need to drive and function at work.  The pain is still there as a constant ache but travels up my spine in the forms of spasms.  I feel it is definitely at the trunk but more pain to the right side.  I have an appoint with a Spinal Pain doctor for next week.
The patient had an injection site reaction (itchy, pink rash/welt), the patient got a script for KEFLEX as she thought it was cellulitis. Her arm is now fine.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 12-OCT-2015, the patient was inadvertently vaccinated with a dose of VARIVAX (Merck) (dose, route and lot # not reported) instead of ZOSTAVAX. No adverse symptoms were reported. Additional information has been requested.
Little Sore Arm; A little tired; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A 33-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection), via an unspecified route of administration on 12Feb2021 (age at vaccination was 33 years,  non pregnant) (Batch/Lot number was not reported) as dose number unknown single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not test COVID-19 positive prior to vaccination. it was unknown that patient had been tested for COVID-19 since the vaccination. On 13Feb2021, after receiving the vaccine the patient experienced little sore arm, a little tired.  The patient did not received treatment for the events. The outcome of the events was unknown.  No follow-up attempts are possible. Information on lot/batch number could not be requested. No further information is expected.
Pain, numbness, aching from right shoulder to right hand.  Loss of grip strength, continuous aching and numbness in arm muscles, extreme fatigue and weakness.  Symptoms have continued to date and have not improved.
T103, high pitch cry, rash-face, trunk, head;mom reports this @ visit 23JUN98 w/6mo immun given that day;